PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BioPlus Acquisition Corp. Unit (BIOSU)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINKYG112171098
SectorFinancial Services
IndustryShell Companies

Highlights

Year Range$10.06 - $11.56

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BioPlus Acquisition Corp. Unit

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in BioPlus Acquisition Corp. Unit, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


BIOSU (BioPlus Acquisition Corp. Unit)
Benchmark (^GSPC)

S&P 500

Returns By Period


PeriodReturnBenchmark
Year-To-DateN/A8.76%
1 monthN/A-0.32%
6 monthsN/A18.48%
1 yearN/A25.36%
5 years (annualized)N/A12.60%
10 years (annualized)N/A10.71%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20230.37%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for BioPlus Acquisition Corp. Unit (BIOSU) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


BIOSU
Sharpe ratio
No data
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.20, compared to the broader market-2.00-1.000.001.002.003.002.20
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.13, compared to the broader market-4.00-2.000.002.004.006.003.13
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.501.001.502.001.38
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.78, compared to the broader market0.002.004.006.001.78
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.43, compared to the broader market-10.000.0010.0020.0030.008.43

Sharpe Ratio

There is not enough data available to calculate the Sharpe ratio for BioPlus Acquisition Corp. Unit. We calculate this metric based on the past 12 months of trading data. Please check back later for updated information.


Rolling 12-month Sharpe Ratio
BIOSU (BioPlus Acquisition Corp. Unit)
Benchmark (^GSPC)

Dividends

Dividend History


BioPlus Acquisition Corp. Unit doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


BIOSU (BioPlus Acquisition Corp. Unit)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the BioPlus Acquisition Corp. Unit. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the BioPlus Acquisition Corp. Unit was 9.12%, occurring on Jun 26, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-9.12%May 4, 202336Jun 26, 2023
-1.39%Dec 14, 202150Feb 24, 2022147Sep 26, 2022197
-0.4%Sep 27, 20221Sep 27, 202216Oct 19, 202217
-0.29%Jan 18, 20231Jan 18, 20238Jan 30, 20239
-0.29%Feb 15, 20231Feb 15, 20239Mar 1, 202310

Volatility

Volatility Chart

The current BioPlus Acquisition Corp. Unit volatility is 0.51%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


BIOSU (BioPlus Acquisition Corp. Unit)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of BioPlus Acquisition Corp. Unit over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items